Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia von O'Hear, Carol, Heiber, Joshua F, Schubert, Ingo, Fey, Georg, Geiger, Terrence L

Volltext

Vesicular Stomatitis Virus Expressing Tumor Suppressor p53 Is a Highly Attenuated, Potent Oncolytic Agent von HEIBER, Joshua F, BARBER, Glen N

Volltext

The Alpha Subunit of Eukaryotic Initiation Factor 2B (eIF2B) Is Required for eIF2-Mediated Translational Suppression of Vesicular Stomatitis Virus von ELSBY, Rachel, HEIBER, Joshua F, REID, Peter, KIMBALL, Scot R, PAVITT, Graham D, BARBER, Glen N

Volltext

Context and location dependence of adaptive Foxp3+ regulatory T cell formation during immunopathological conditions von Heiber, Joshua F., Geiger, Terrence L.

Volltext

PS2-068 Vesicular stomatitis virus (VSV) expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent von Heiber, Joshua F., Ahn, Jeonghyun, Barber, Glen N.

Volltext

SS5-7 Development of recombinant vesicular stomatitis virus that modulate immunity for use as an oncolytic vector von Heiber, Joshua F., Acevedo, Jennifer, Gutman, Delia, Elsby, Rachel, Barber, Glen N.

Volltext

Explicit targeting of transformed cells by VSV in ovarian epithelial tumor-bearing Wv mouse models von Capo-chichi, Callinice D, Yeasky, Toni M, Heiber, Joshua F, Wang, Ying, Barber, Glen N, Xu, Xiang-Xi

Volltext

Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer von Heiber, Joshua F, Xu, Xiang-Xi, Barber, Glen N

Volltext

Evaluation of Innate Immune Signaling Pathways in Transformed Cells von Heiber, Joshua F., Barber, Glen N.

Volltext

TheAlpha Subunit of Eukaryotic Initiation Factor 2B (eIF2B) Is Required for eIF2-Mediated Translational Suppression of Vesicular Stomatitis Virus von Elsby, Rachel, Heiber, Joshua F, Reid, Peter, Kimball, Scot R, Pavitt, Graham D, Barber, Glen N

Volltext